RSV vaccine for babies in limited supply
Beyfortus is used for infants labeled as high-risk and those under six months of age with underlying health conditions.
•
Oct 23, 2023, 11:47 PM
•
Updated 349 days ago
Share:
More Stories
1:43
There's more than 1 serious form of meningitis. What you need to know
18h ago2:17
Study: More women under 50 are being diagnosed with breast cancer
yesterday1:40
Focus on your health and wellness journey at The Ranch Hudson Valley
3ds ago2:14
Friends in Rockland mark 10 years fundraising for breast cancer awareness, support
4ds ago1:02
American Cancer Society releases new report during Breast Cancer Awareness Month
5ds ago1:51
be Well: Common fall allergy symptoms
5ds ago1:43
There's more than 1 serious form of meningitis. What you need to know
18h ago2:17
Study: More women under 50 are being diagnosed with breast cancer
yesterday1:40
Focus on your health and wellness journey at The Ranch Hudson Valley
3ds ago2:14
Friends in Rockland mark 10 years fundraising for breast cancer awareness, support
4ds ago1:02
American Cancer Society releases new report during Breast Cancer Awareness Month
5ds ago1:51
be Well: Common fall allergy symptoms
5ds agoSupply of Beyfortus, the vaccine used to protect infants against respiratory syncytial virus (RSV), is in limited supply due to high demand, according to the Centers for Disease Control.
Beyfortus is used for infants labeled as high-risk and those under six months of age with underlying health conditions.
More from News 12
1:42
White Plains vigil marks 1 year since Oct. 7 terror attacks
1:21
Local organizations collect donations for communities affected by Hurricane Helene
Frank Fritz of the reality TV Show 'American Pickers' dies at 60
Many Verizon customers across the US hit by service outage
0:31
NBA Hall of Famer Dikembe Mutombo dies at 58 from brain cancer
